Gupta Vandana, Keshari Bipin Bihari, Tiwari S K, Murthy K H H V S S Narasimha
Department of Kayachikitsa, VYDS Ayurvedic College, Khurja, Uttar Pradesh, India.
Department of Maulika Sidhanta, VYDS Ayurvedic College, Khurja, Uttar Pradesh, India.
Ayu. 2016 Apr-Jun;37(2):120-124. doi: 10.4103/ayu.AYU_211_15.
Diabetes mellitus is becoming an alarming problem for society nowadays causing impediment in normal life. Diabetes and its complications impose a major burden upon health-care facilities.
In this study, 90 patients of (type-2 diabetes mellitus) were registered and randomly divided into two groups. Out of 90 registered patients, 80 patients completed the treatment. In Group A, cap. (500 mg twice daily) was given for 3 months and in Group B, (2 twice daily) was given for 3 months.
An attempt was made to evaluate and compare the efficacy of and in the management of type-2 diabetes mellitus. The efficacy of therapy was assessed on the basis of improvement in sign and symptoms of diabetes mellitus, blood sugar level, and glycosylated hemoglobin.
Statistically significant improvement was observed in sign and symptoms as well as on blood sugar level in both groups after the completion of treatment.
and seem to be effective and completely safe for the management of (type-2 diabetes mellitus).
如今，糖尿病正成为一个令社会担忧的问题，给正常生活带来阻碍。糖尿病及其并发症给医疗保健机构带来了重大负担。
在本研究中，登记了90例2型糖尿病患者，并随机分为两组。在90例登记患者中，80例完成了治疗。A组给予（每日两次，每次500毫克），持续3个月；B组给予（每日两次，每次2），持续3个月。
试图评估和比较在2型糖尿病管理中的疗效。根据糖尿病体征和症状的改善情况、血糖水平以及糖化血红蛋白来评估治疗效果。
治疗完成后，两组在体征和症状以及血糖水平方面均观察到具有统计学意义的改善。
和在2型糖尿病的管理中似乎有效且完全安全。
